NCT02104037已完成不适用
Liraglutide in Spinal Fluid
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 8
- 试验地点
- 2
- 主要终点
- cerebrospinal fluid concentration of liraglutide
研究概览
简要总结
The purpose of this study is to investigate transfer of liraglutide from blood to cerebrospinal fluid.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 2 diabetes treated with liraglutide 1.8 mg for 1 month and 5% weight loss
排除标准
- 未提供
研究组 & 干预措施
Liraglutide treated patients
Experimental
干预措施: Lumbar puncture (Procedure)
结局指标
主要结局
cerebrospinal fluid concentration of liraglutide
时间窗: time 60 minutes
次要结局
未报告次要终点
研究者
Mikkel Christensen
Dr.
University Hospital, Gentofte, Copenhagen
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Cerebrospinal Fluid (CSF) Raltegravir SubstudyHIV InfectionsNCT00718029University of California, San Diego4
尚未招募
不适用
Analysis of lactate in cerebrospinal fluid in meningitis patients.meningitisJPRN-UMIN000048085Saitama Medical University International Medical Center100
已完成
不适用
A study to examine cerebrospinal fluid transitivity and efficacy of afatinib in carcinomatous meningitis patients with non-small cell lung cancer patients harboring EGFR mutation.carcinomatous meningitis patients with NSCLC harboring EGFR mutationJPRN-UMIN000014065Kinki-Chuo Chest Medical Center10
招募中
4 期
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 DiabetesStroke (CVA) or Transient Ischemic AttackDiabetes Mellitus, Type 2NCT05780905University of Washington50
进行中（未招募）
3 期
Does removal of cerebrospinal fluid from lowerback in surgery for the pituitary tumor decrease the cerebrospinal fluid leak through the noseCTRI/2014/09/005021CMC Vellore IRB60